Form 4: CBNK Director Whalen Boosts Stake with RSU, Option Grants
Insider Transaction Report
Capital Bancorp Inc. Director James F. Whalen acquired new Restricted Stock Units and Stock Options, increasing his potential beneficial ownership.
Summary
- Director James F. Whalen acquired 1,836 Restricted Stock Units (RSUs) on March 2, 2026, which are scheduled to vest on March 2, 2027.
- Whalen also acquired 7,096 Stock Options on March 2, 2026, with an exercise price of $29.41. These options will vest in four equal annual installments beginning March 2, 2027, and expire on March 2, 2031.
- On March 3, 2026, 1,081 Restricted Stock Units vested and were converted into common stock.
- Following these transactions, Whalen's indirect beneficial ownership of common stock totals 973,005 shares, held across the James F. Whalen Revocable Trust (668,554 shares), IRA (58,400 shares), Whalen Family, LLC (240,409 shares), NMW Investments LLC (2,821 shares), and KAW Investments LLC (2,821 shares).
- Whalen also holds additional stock options: 3,485 at an exercise price of $23.54 (vesting from 01/01/2024, expiring 01/01/2028), 2,750 at $26.41 (vesting from 12/31/2022, expiring 12/31/2026), 4,400 at $24.20 (vesting from 01/01/2025, expiring 01/01/2029), and 4,000 at $30.51 (vesting from 03/03/2026, expiring 03/03/2030).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as insider acquisitions of equity compensation generally indicate confidence in the company's future prospects and align the director's interests with shareholders.
Positives
- Director James F. Whalen received a grant of 1,836 Restricted Stock Units, aligning his interests with long-term shareholder value.
- Whalen was granted 7,096 stock options, providing an incentive for future company performance.
- The vesting of 1,081 Restricted Stock Units demonstrates the realization of previously granted equity compensation.
- The transactions increase the director's overall potential beneficial ownership in Capital Bancorp Inc.
Future Outlook
The filing details future vesting schedules for Restricted Stock Units and Stock Options, indicating a long-term incentive structure for the director.
Industry Context
StockSavvy.ai notes that equity grants to directors are a common practice in the financial services industry, aligning management and board interests with shareholder returns. These grants typically serve as long-term incentives, encouraging sustained performance and strategic growth within the banking sector.
Related Party Transactions
- James F. Whalen holds indirect beneficial ownership through the James F. Whalen Revocable Trust, Whalen Family, LLC, NMW Investments LLC, and KAW Investments LLC.
Stakeholder Impact
- Shareholders: Increased alignment of a director's interests with long-term shareholder value through equity compensation.
- Management: Reinforces incentive structure for the director based on company performance.
Next Steps
- 1,836 Restricted Stock Units will vest on March 2, 2027.
- 7,096 Stock Options will vest in four equal annual installments beginning March 2, 2027.
- Existing stock options will continue to vest according to their respective schedules.
Key Dates
| Date | Description |
|---|---|
| 12/31/2022 | Start of vesting for 2,750 stock options with an exercise price of $26.41, expiring 12/31/2026. |
| 01/01/2024 | Start of vesting for 3,485 stock options with an exercise price of $23.54, expiring 01/01/2028. |
| 01/01/2025 | Start of vesting for 4,400 stock options with an exercise price of $24.20, expiring 01/01/2029. |
| 03/02/2026 | Acquisition date for 1,836 Restricted Stock Units and 7,096 Stock Options. |
| 03/03/2026 | Vesting date for 1,081 Restricted Stock Units and acquisition of 4,000 stock options with an exercise price of $30.51. |
| 12/31/2026 | Expiration date for 2,750 stock options with an exercise price of $26.41. |
| 03/02/2027 | Vesting date for 1,836 Restricted Stock Units and start of four equal annual installments vesting for 7,096 stock options. |
| 01/01/2028 | Expiration date for 3,485 stock options with an exercise price of $23.54. |
| 01/01/2029 | Expiration date for 4,400 stock options with an exercise price of $24.20. |
| 03/03/2030 | Expiration date for 4,000 stock options with an exercise price of $30.51. |
| 03/02/2031 | Expiration date for 7,096 stock options with an exercise price of $29.41. |
Recommendation
holdThe acquisition of Restricted Stock Units and Stock Options by a director is a positive indicator of insider confidence and aligns management's interests with long-term shareholder value. However, these are grants as part of compensation rather than open market purchases, suggesting a 'hold' recommendation as it reinforces existing positive sentiment without providing a new, compelling reason for a 'buy' or 'strong buy' based solely on this filing.
Keywords
Capital Bancorp Inc, CBNK, James F. Whalen, Director, SEC Form 4, Insider Transaction, Restricted Stock Units, Stock Options, Equity Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.